A carregar...
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
Cardiac amyloidosis is a restrictive cardiomyopathy that results from the deposition of misfolded light chain or transthyretin proteins, most commonly, in cardiac tissue. Traditionally, treatment options for light chain (AL) and transthyretin (ATTR) amyloidosis have been limited. However, there are...
Na minha lista:
| Publicado no: | JACC Basic Transl Sci |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609907/ https://ncbi.nlm.nih.gov/pubmed/31312767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2019.02.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|